Search for a trial

1 results

OPEN-LABEL, MULTI-CENTER, SINGLE-ARM STUDY FOR THE SAFETY AND EFFICACY OF
POMALIDOMIDE (CC-4047) MONOTHERAPY FOR SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA. A COMPANION STUDY FOR CLINICAL TRIALCC-4047-MM-003.

Approved WMORecruitment stopped

The primary objective is:To evaluate the efficacy of pomalidomide (CC-4047) monotherapy in subjects with refractory orrelapsed and refractory multiple myeloma who discontinued treatment after being treated withdexamethasone alone (Treatment Arm B)…

OPEN-LABEL, MULTI-CENTER, SINGLE-ARM STUDY FOR THE SAFETY AND EFFICACY OF POMALIDOMIDE (CC-4047) MONOTHERAPY FOR SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA. A COMPANION STUDY FOR CLINICAL TRIALCC-4047-MM-003.

OPEN-LABEL, MULTI-CENTER, SINGLE-ARM STUDY FOR THE SAFETY AND EFFICACY OF
POMALIDOMIDE (CC-4047) MONOTHERAPY FOR SUBJECTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA. A COMPANION STUDY FOR CLINICAL TRIALCC-4047-MM-003.